Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis.

Bearden CE, Wu KN, Caplan R, Cannon TD.

J Am Acad Child Adolesc Psychiatry. 2011 Jul;50(7):669-80. doi: 10.1016/j.jaac.2011.03.021. Epub 2011 Jun 2.

2.

Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA; North American Prodrome Longitudinal Study (NAPLS) Group.

Arch Gen Psychiatry. 2010 Jun;67(6):578-88. doi: 10.1001/archgenpsychiatry.2010.66.

3.

The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.

Addington J, Liu L, Perkins DO, Carrion RE, Keefe RS, Woods SW.

Schizophr Bull. 2017 Jan;43(1):57-63. doi: 10.1093/schbul/sbw152. Epub 2016 Oct 25.

PMID:
27798225
4.

Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.

De Herdt A, Wampers M, Vancampfort D, De Hert M, Vanhees L, Demunter H, Van Bouwel L, Brunner E, Probst M.

Schizophr Res. 2013 Sep;149(1-3):48-55. doi: 10.1016/j.schres.2013.06.017. Epub 2013 Jul 5. Review.

PMID:
23830855
5.

Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.

Perez VB, Woods SW, Roach BJ, Ford JM, McGlashan TH, Srihari VH, Mathalon DH.

Biol Psychiatry. 2014 Mar 15;75(6):459-69. doi: 10.1016/j.biopsych.2013.07.038. Epub 2013 Sep 16.

6.

Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.

Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, Bearden CE, Cannon TD.

Schizophr Bull. 2012 Nov;38(6):1225-33. doi: 10.1093/schbul/sbr098. Epub 2011 Aug 8.

7.

The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis.

Nieman DH, Velthorst E, Becker HE, de Haan L, Dingemans PM, Linszen DH, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, Morrison A, Schultze-Lutter F, Klosterkötter J, Ruhrmann S; EPOS group.

Acta Psychiatr Scand. 2013 Jan;127(1):53-61. doi: 10.1111/j.1600-0447.2012.01899.x. Epub 2012 Jul 7.

PMID:
22775300
8.

Affect recognition in people at clinical high risk of psychosis.

Addington J, Piskulic D, Perkins D, Woods SW, Liu L, Penn DL.

Schizophr Res. 2012 Sep;140(1-3):87-92. doi: 10.1016/j.schres.2012.06.012. Epub 2012 Jul 3.

9.

The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.

Carrión RE, McLaughlin D, Auther AM, Olsen R, Correll CU, Cornblatt BA.

Psychol Med. 2015 Nov;45(15):3341-54. doi: 10.1017/S0033291715001233. Epub 2015 Jul 14.

10.

Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.

Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW.

JAMA Psychiatry. 2016 Dec 1;73(12):1239-1248. doi: 10.1001/jamapsychiatry.2016.2479.

PMID:
27806157
11.

Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis.

Sabb FW, van Erp TG, Hardt ME, Dapretto M, Caplan R, Cannon TD, Bearden CE.

Schizophr Res. 2010 Feb;116(2-3):173-83. doi: 10.1016/j.schres.2009.09.042. Epub 2009 Oct 27.

12.

Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.

Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS.

Early Interv Psychiatry. 2015 Dec;9(6):467-75. doi: 10.1111/eip.12128. Epub 2014 Feb 27.

13.

From lumping to splitting and back again: atypical social and language development in individuals with clinical-high-risk for psychosis, first episode schizophrenia, and autism spectrum disorders.

Solomon M, Olsen E, Niendam T, Ragland JD, Yoon J, Minzenberg M, Carter CS.

Schizophr Res. 2011 Sep;131(1-3):146-51. doi: 10.1016/j.schres.2011.03.005. Epub 2011 Mar 31.

14.

Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.

Lee TY, Shin YS, Shin NY, Kim SN, Jang JH, Kang DH, Kwon JS.

Schizophr Res. 2014 Mar;153(1-3):48-53. doi: 10.1016/j.schres.2014.01.018. Epub 2014 Feb 13.

PMID:
24529365
15.

Coping styles of individuals at clinical high risk for developing psychosis.

Jalbrzikowski M, Sugar CA, Zinberg J, Bachman P, Cannon TD, Bearden CE.

Early Interv Psychiatry. 2014 Feb;8(1):68-76. doi: 10.1111/eip.12005. Epub 2012 Nov 19.

16.

Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.

Armando M, Pontillo M, De Crescenzo F, Mazzone L, Monducci E, Lo Cascio N, Santonastaso O, Pucciarini ML, Vicari S, Schimmelmann BG, Schultze-Lutter F.

Schizophr Res. 2015 Dec;169(1-3):186-192. doi: 10.1016/j.schres.2015.10.033. Epub 2015 Oct 29.

PMID:
26526751
17.

Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.

Buchy L, Perkins D, Woods SW, Liu L, Addington J.

Schizophr Res. 2014 Jul;156(2-3):277-80. doi: 10.1016/j.schres.2014.04.021. Epub 2014 May 14.

18.

Social inference in individuals at clinical high risk for psychosis.

Gill KE, Cressman V, Poe SL, Steinfeld S, Ben-David S, Keilp JG, Moore H, Turkstra LS, Corcoran C.

Early Interv Psychiatry. 2016 Feb;10(1):77-80. doi: 10.1111/eip.12182. Epub 2014 Sep 9.

PMID:
25203733
19.

Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.

Auther AM, McLaughlin D, Carrión RE, Nagachandran P, Correll CU, Cornblatt BA.

Psychol Med. 2012 Dec;42(12):2485-97. doi: 10.1017/S0033291712000803. Epub 2012 Apr 30.

20.

North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.

Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH.

J Nerv Ment Dis. 2015 May;203(5):328-35. doi: 10.1097/NMD.0000000000000290.

Supplemental Content

Support Center